Login to Your Account

Photocure Preps for Phase III with HPV PTD Therapy Cervira

By Nuala Moran
Staff Writer

Wednesday, April 17, 2013
Photocure ASA claimed it has taken photodynamic therapy (PDT) "to a completely new level," as it published positive data from the final analysis of the 262-patient Phase IIb trial of Cervira in treating oncogenic human papillomavirus (HPV) infections and pre-cancerous lesions of the cervix.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription